Allogeneic CAR T cell therapy may be a safe and feasible treatment for relapsed refractory multiple myeloma patients | NMDP

Research
Research & Publications

National Marrow Donor Program - Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including NMDP Registry℠.

Copyright © 2026 National Marrow Donor Program. All Rights Reserved.

Privacy Policy Terms of Use Trademark & Copyright